Evidence map›Paper›PMID 31943336›Full record

ArticleImmunology and cell biology2020

Dimethyl itaconate protects against fungal keratitis by activating the Nrf2/HO-1 signaling pathway.

Lingwen Gu, Jing Lin, Qian Wang, Cui Li, Xudong Peng, Yiqun Fan, Chunli Lu, Hao Lin, Yawen Niu, Guoqiang Zhu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Immunology and cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 77 citations in OpenAlex.

  1. Itaconate and its derivatives in human health and diseases.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The role and therapeutic potential of itaconate in lung disease.Cellular & molecular biology letters · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Modern Technologies in Diagnosis of Fungal Keratitis (Review).Sovremennye tekhnologii v meditsine · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lingwen GuDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Jing LinDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qian WangDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Cui LiDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xudong PengDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yiqun FanDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chunli LuDepartment of Medicine, Qingdao University, Qingdao, China.
Hao LinDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yawen NiuDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guoqiang ZhuDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guiqiu ZhaoDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qingdao University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dimethyl itaconate (DI) is a membrane-permeable itaconate derivative with anti-inflammatory functions. However, the anti-inflammatory effect of DI has never been studied in fungal keratitis. In this study, we tested the protective effect of DI against fungal keratitis and assessed the role of NF-E2-related factor-2 (Nrf2)/heme oxygenase-1 (HO-1) signaling in this process. Eyes of C57BL/6 (B6) mice were treated with 2 mm DI after infection with Aspergillus fumigatus. Human corneal epithelial cells (HCECs) were pretreated with 0.25 mm DI and then incubated with A. fumigatus. Clinical scoring, slit-lamp photography, myeloperoxidase determination, flow cytometry and immunostaining were used to assess the disease response and treatment efficacy. PCR, Western blot and ELISA were used to assess the expression of interleukin-1β (IL-1β), chemokine (C-X-C motif) ligand 1, IL-6, IL-8, Nrf2 and HO-1. In addition, quantification of viable fungi, absorbance assays and fluorimetry were used to measure DI fungistatic activity. We observed that DI-treated eyes showed decreased clinical scores, fungal loads, polymorphonuclear neutrophil (PMN) infiltration and cytokine expression, compared with phosphate-buffered saline-treated infected eyes. DI treatment decreased the cytokine levels in infected corneas and in HCECs stimulated with A. fumigatus. Moreover, DI treatment increased Nrf2 and HO-1 expression in corneas and nuclear Nrf2 accumulation in HCECs. DI-induced cytokine downregulation was inhibited by pretreatment with an Nrf2 or HO-1 inhibitor. Finally, DI treatment reduced the A. fumigatus absorbance and fungal mass. These data indicate that DI protects against fungal keratitis by limiting inflammation via the Nrf2/HO-1 signaling pathway and that DI inhibits the growth of A. fumigatus.

Indexed as

AnimalsAspergillosisAspergillus fumigatusChemokine CXCL1CorneaEpithelial CellsEpithelium, CornealHeme Oxygenase-1HumansInflammationInterleukin-6Interleukin-8KeratitisMiceNF-E2-Related Factor 2Signal TransductionChemokine CXCL1Cxcl1 protein, mousedimethyl itaconateHeme Oxygenase-1Interleukin-6interleukin-6, mouseInterleukin-8Nfe2l2 protein, mouseNF-E2-Related Factor 2SuccinatesDimethyl itaconatefungal keratitisinflammationtreatment

Identifiers

PMID31943336
PMCPMC7065235
OpenAlexW2999371982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.